ExRNA communication is a recently discovered cell-to-cell signaling process that holds enormous promise for improving our understanding of a wide variety of diseases. NCATS participates in the NIH Common Fund's program to investigate this new scientific field.
-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- NCATS Programs & Initiatives
- NIH Common Fund Programs
- Extracellular RNA Communication (ExRNA)
Extracellular RNA Communication (ExRNA)
Repurposed Drug Approach May Thwart Spread of Cancer Cells
NCATS pre-clinical staff helped NIH Extracellular RNA Communication program-supported scientists use a new approach to find drugs that may help prevent the spread of prostate cancer.
About ExRNA CommunicationGet more information about the NIH Common Fund’s exRNA Communication program and NCATS’ participation.
ExRNA Communication Funding InformationLearn how NIH Institutes and Centers, including NCATS, administer exRNA support from the NIH Common Fund.
ExRNA Communication ProjectsFind out more about the exRNA projects that NCATS administers through the NIH Common Fund.
Get more information about the NIH Common Fund’s exRNA Communication program and NCATS’ participation.
ExRNA Communication Funding Information
Learn how NIH Institutes and Centers, including NCATS, administer exRNA support from the NIH Common Fund.
Find out more about the exRNA projects that NCATS administers through the NIH Common Fund.
Work with Us
A better understanding of basic exRNA biology could open doors to improving the diagnosis, prognosis and treatment of diseases and conditions such as cancer, bone marrow disorders, heart disease, Alzheimer's disease and multiple sclerosis.
The Promise of ExRNA
Scientists are only beginning to understand the potential that exRNA research may hold for improving diagnosis, prognosis and treatment of a wide range of diseases and conditions. But researchers need to know more about basic exRNA biology first.
To advance this new field of research and address a collective scientific need, NIH launched the Extracellular RNA Communication program in July 2012. NCATS is currently administering six awards as part of the second phase of the program. Learn more about the ExRNA Communication program.
More About ExRNA
Explore cutting-edge science through the exRNA Research Portal.
View frequently asked questions about the ExRNA Communication program.
NCATS Programs & Initiatives
- News & Media
- Funding & Notices
-